Discriminating lymphomas and reactive lymphadenopathy in lymph node biopsies by gene expression profiling
暂无分享,去创建一个
Anna Campain | Y. H. Yang | M. Lutherborrow | David D. F. Ma | J. Turner | A. Campain | T. Molloy | Mark Lutherborrow | A. Bryant | To Ha Loi | Adam Bryant | Tim J Molloy | Jennifer Turner | Yee Hwa Jean Yang | David DF Ma | T. Loi
[1] Richard Baumgartner,et al. Class prediction and discovery using gene microarray and proteomics mass spectroscopy data: curses, caveats, cautions , 2003, Bioinform..
[2] G. T. te Meerman,et al. Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22 , 2008, British journal of haematology.
[3] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[4] J. Welsh,et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. , 2001, Cancer research.
[5] D. Hossfeld. E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues , 2002 .
[6] A. Rosenwald,et al. Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP. , 2008, Blood.
[7] G. V. Ommen,et al. Medical genomics , 2001, European Journal of Human Genetics.
[8] Todd,et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning , 2002, Nature Medicine.
[9] T. Golub,et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. , 2004, Blood.
[10] Richard Simon,et al. Molecular diagnosis of Burkitt's lymphoma. , 2006, The New England journal of medicine.
[11] I. Boros,et al. TATA binding protein associated factor 3 (TAF3) interacts with p53 and inhibits its function , 2008, BMC Molecular Biology.
[12] L. Staudt,et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.
[13] U. Alon,et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[14] Karey Shumansky,et al. Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). , 2005, Blood.
[15] Qiqin Yin-Goen,et al. Molecular classification of renal tumors by gene expression profiling. , 2005, The Journal of molecular diagnostics : JMD.
[16] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[17] Juan F. García,et al. Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma. , 2006, Blood.
[18] Steven H Kroft,et al. Overexpression of CD7 in classical Hodgkin lymphoma‐infiltrating T lymphocytes , 2009, Cytometry. Part B, Clinical cytometry.
[19] R. Küppers,et al. Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma. , 2009, Annual review of pathology.
[20] E. Jaffe. Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues , 2003 .
[21] T. Golub,et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. , 2003, Blood.
[22] I. Lossos,et al. The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. , 2007, Blood.
[23] Yee Hwa Yang,et al. Preprocessing Two-Color Spotted Arrays , 2005 .
[24] C. Stephan,et al. Robust microRNA stability in degraded RNA preparations from human tissue and cell samples. , 2010, Clinical chemistry.
[25] Mike Scott,et al. Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray , 2006, British journal of haematology.
[26] J. Chi,et al. Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma , 2008, Journal of cellular and molecular medicine.
[27] Ash A. Alizadeh,et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. , 2004, The New England journal of medicine.
[28] Eytan Domany,et al. Outcome signature genes in breast cancer: is there a unique set? , 2004, Breast Cancer Research.
[29] J Kaldor,et al. Use of the WHO lymphoma classification in a population-based epidemiological study. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[30] Rafael A. Irizarry,et al. Bioinformatics and Computational Biology Solutions using R and Bioconductor , 2005 .
[31] J. Davis. Bioinformatics and Computational Biology Solutions Using R and Bioconductor , 2007 .
[32] L. Staudt,et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. , 2004, Blood.
[33] A. Rosenwald,et al. Germinal Center B Cell-Like (GCB) and Activated B Cell-Like (ABC) Type of Diffuse Large B Cell Lymphoma (DLBCL): Analysis of Molecular Predictors, Signatures, Cell Cycle State and Patient Survival , 2007, Cancer informatics.